[ad_1]
A vaccine against the deadly corona virus, which has caused global panic, will be tested experimentally in humans on Thursday. The name of the vaccine is CHADOX1 Encov-19.
The announcement was made by British Health Minister Matt Hancock at a regular briefing on Corona’s situation in London on Tuesday.
If the vaccine, developed by scientists at the University of Oxford, is successful, the entire world will be saved from a major catastrophe. BBC News.
Matt Hancock announced that the CHADOX-1 ENCOV-19 vaccine, a joint venture between the University of Oxford and Imperial College London, would be administered to humans next Thursday.
He said the British government would provide বিজ্ঞান 20 million to scientists at Oxford University and 22.5 million to Imperial College to help implement the vaccine project. We are hopeful that this vaccine will finally be applied to the human body by next September. The vaccine is targeted at several million doses.
Previously, scientists at Oxford University in the United Kingdom had said that 1 million coronavirus vaccines would be launched in September. The vaccine will be administered to humans in the UK this week, and scientists say they are ready to experiment with the vaccine.
On April 19, Adrian Hill, a professor at Oxford University, said: “We started production before the corona vaccine was introduced into the human body. First we are preparing a 3-liter dose. Then 50 liters will be produced, 100 liters, 200 liters and even 2000 liters If the results are good, they will initially be out of the market.
Oxford University was established in 2005 with funds from the British government and various British charities. The goal is to research and develop vaccines against infectious diseases. Edward Jenner is said to be the father of the vaccine. Guti was one of the inventors of the spring vaccine about 200 years ago. He didn’t stop inventing the smallpox vaccine. His contribution to attracting a large part of the population under this vaccine is eternal.
The scientist of this organization said. Sarah Gilbert. It works with viruses. A team of Oxford scientists led by Saraha began work on the vaccine in January. In March, a British government agency provided a grant of Rs 22 crore for the study. Sarah and her team have previous experience in developing vaccines for other infectious diseases. This experience is expected to play an important role in the development of experimental coronary vaccines.
Dhaka Times / April 22 / MR
[ad_2]
